James RA - Search Results

1

Effects of recombinant human activin A on growth hormone secretion by human somatotrophinomas in vitro.

Daniels M, Harris PE, James RA, Turner SJ, Dewar JH, Kendall-Taylor P. Daniels M, et al. Among authors: james ra. J Endocrinol. 1993 May;137(2):329-34. doi: 10.1677/joe.0.1370329. J Endocrinol. 1993. PMID: 8326258

2

Actions of L-363,586, a cyclic hexapeptide analogue of somatostatin, on GH secretion by human somatotrophinoma cells in vitro.

Daniels M, James RA, Harris PE, Turner SJ, Dewar J, Kendall-Taylor P. Daniels M, et al. Among authors: james ra. Life Sci. 1991;49(16):1207-12. doi: 10.1016/0024-3205(91)90569-w. Life Sci. 1991. PMID: 1680212

3

Effects of insulin-like growth factor-II on growth hormone release from human somatotrophinoma cells in vitro.

Harris PE, Daniels M, James RA, Turner SJ, Dewar J, Kendall-Taylor P. Harris PE, et al. Among authors: james ra. J Endocrinol. 1991 Jun;129(3):447-51. doi: 10.1677/joe.0.1290447. J Endocrinol. 1991. PMID: 2066699

4

Oncoprotein immunoreactivity in human pituitary tumours.

Raghavan R, Harrison D, Ince PG, James RA, Daniels M, Birch P, Caldwell GI, Kendall-Taylor P. Raghavan R, et al. Among authors: james ra. Clin Endocrinol (Oxf). 1994 Jan;40(1):117-26. doi: 10.1111/j.1365-2265.1994.tb02453.x. Clin Endocrinol (Oxf). 1994. PMID: 8306470

5

Carbohydrate tolerance and serum lipids in acromegaly before and during treatment with high dose octreotide.

James RA, Møller N, Chatterjee S, White M, Kendall-Taylor P. James RA, et al. Diabet Med. 1991 Jul;8(6):517-23. doi: 10.1111/j.1464-5491.1991.tb01644.x. Diabet Med. 1991. PMID: 1832350

6

Administration of high-dose octreotide (Sandostatin) by continuous subcutaneous infusion for the treatment of acromegaly.

White MC, James RA, Chatterjee S, Mother M, Hall K, Dunne MJ, Baister ER, Kendall-Taylor P. White MC, et al. Among authors: james ra. Horm Res. 1990;33 Suppl 1:13-8; discussion 18-9. doi: 10.1159/000181550. Horm Res. 1990. PMID: 1972690

7

Continuous infusion of octreotide in acromegaly.

James RA, Chatterjee S, White MC, Hall K, Moller N, Kendall-Taylor P. James RA, et al. Lancet. 1989 Nov 4;2(8671):1083-7. doi: 10.1016/s0140-6736(89)91092-1. Lancet. 1989. PMID: 2572807

8

Factors determining the long-term outcome of surgery for acromegaly.

Osman IA, James RA, Chatterjee S, Mathias D, Kendall-Taylor P. Osman IA, et al. Among authors: james ra. QJM. 1994 Oct;87(10):617-23. QJM. 1994. PMID: 7987657

9

Optic chiasmal herniation--an under recognized complication of dopamine agonist therapy for macroprolactinoma.

Jones SE, James RA, Hall K, Kendall-Taylor P. Jones SE, et al. Among authors: james ra. Clin Endocrinol (Oxf). 2000 Oct;53(4):529-34. doi: 10.1046/j.1365-2265.2000.01039.x. Clin Endocrinol (Oxf). 2000. PMID: 11012580

10

Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?

Chee GH, Mathias DB, James RA, Kendall-Taylor P. Chee GH, et al. Among authors: james ra. Clin Endocrinol (Oxf). 2001 May;54(5):617-26. doi: 10.1046/j.1365-2265.2001.01261.x. Clin Endocrinol (Oxf). 2001. PMID: 11380492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters